AstraZeneca wins speedy approvals for cancer drugs in Japan
July 02, 2018 at 03:07 AM EDT
LONDON, July 2 (Reuters) - AstraZeneca has won rapid regulatory approval for new uses of two of its important cancer drugs in Japan, less than six months after the first global approvals in Western markets.